Cargando…
Clinical and FDG-PET/CT Suspicion of Malignant Disease: Is Biopsy Confirmation Still Necessary?
Background: Biopsy of (18)F-fluoro-2-deoxy-D-glucose (FDG)-avid lesions suspected for malignancy remains an invasive procedure associated with a variety of risks. It is still unclear if the positive predictive value (PPV) of positron emission tomography (PET)/computed tomography (CT) is sufficiently...
Autores principales: | Bent, Talitha, Yakar, Derya, Kwee, Thomas C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003997/ https://www.ncbi.nlm.nih.gov/pubmed/33804753 http://dx.doi.org/10.3390/diagnostics11030559 |
Ejemplares similares
-
The value of prebiopsy FDG-PET/CT in discriminating malignant from benign vertebral bone lesions in a predominantly oncologic population
por: Loudini, Naila, et al.
Publicado: (2020) -
Malignancy rate of biopsied suspicious bone lesions identified on FDG PET/CT
por: Adams, Hugo J. A., et al.
Publicado: (2016) -
Dealing with a soft tissue lesion that is scheduled for CT-guided biopsy and that has decreased in size on preprocedural planning CT
por: Yakar, Derya, et al.
Publicado: (2020) -
Clinical implications of increased uptake in bone marrow and spleen on FDG-PET in patients with bacteremia
por: Pijl, Jordy P., et al.
Publicado: (2020) -
FDG PET/CT in carcinoma of unknown primary
por: Kwee, Thomas C., et al.
Publicado: (2009)